Exhibit II
to
Schedule 13G
Joint Filing Agreement
The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated January 8, 2016 in connection with their beneficial ownership of Intercept Pharmaceuticals, Inc. Each of Columbia Select Large Cap Growth Fund and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
| Ameriprise Financial, Inc. | ||
| By: | /s/ Amy Johnson | |
| Amy Johnson | ||
| Senior Vice President and Chief Operating Officer-Asset Management | ||
| Columbia Management Investment Advisers, LLC | ||||
| By: | /s/ Amy Johnson | |||
| Amy Johnson | ||||
| Chief Operating Officer and Managing Director | ||||
| Columbia Select Large Cap Growth Fund | ||
| By: | /s/ Paul Goucher | |
| Paul Goucher | ||
| Senior Vice President, Chief Legal Officer and Assistant Secretary | ||
